Surveillance decision

Surveillance decision

We will not update the guideline on developing and updating local formularies.

Reasons for the decision

During this surveillance review, no new evidence was identified relevant to the processes and systems for developing and updating local formularies. The absence of evidence suggests that an update of the NICE guideline recommendations is not needed at present.

For further details and a summary of all evidence identified in surveillance, see appendix A.


This page was last updated: